Literature DB >> 20813465

ACR Appropriateness Criteria® on Induction and Adjuvant Therapy for Stage N2 Non-Small-Cell Lung Cancer: expert panel on radiation oncology-lung.

Ramesh S Gopal1, Sarita Dubey, Kenneth E Rosenzweig, Joe Yujiao Chang, Roy Decker, Richard M Gewanter, Feng-Ming Kong, Brian E Lally, Corey J Langer, Hoon Ku Lee, Benjamin Movsas.   

Abstract

"The American College of Radiology seeks and encourages collaboration with other organizations on the development of the ACR Appropriateness Criteria through society representation on expert panels. Participation by representatives from collaborating societies on the expert panel does not necessarily imply society endorsement of the final document."
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2010        PMID： 20813465     DOI： 10.1016/j.ijrobp.2010.07.028

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


  6 in total

1.  Optimal sequencing of postoperative radiotherapy and chemotherapy in IIIA-N2 non-small cell lung cancer.

Authors:  Ugur Selek; Joe Y Chang
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

2.  [Interdisciplinary treatment of non-small cell lung cancer].

Authors:  J Dunst; C Kugler; D Ukena
Journal:  Internist (Berl)       Date:  2011-02       Impact factor: 0.743

3.  Sequencing postoperative radiotherapy and adjuvant chemotherapy in non-small cell lung cancer: unanswered questions on the not evidence-based approach.

Authors:  Lucyna Kepka; Joanna Socha; Monika Rucinska; Ewa Wasilewska-Tesluk; Katarzyna Komosinska
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

4.  Delineation of clinical target volume for postoperative radiotherapy in stage IIIA-pN2 non-small-cell lung cancer.

Authors:  Xuquan Jing; Xue Meng; Xindong Sun; Jinming Yu
Journal:  Onco Targets Ther       Date:  2016-02-19       Impact factor: 4.147

5.  Radiation recall pneumonitis triggered by an immune checkpoint inhibitor following re-irradiation in a lung cancer patient: a case report.

Authors:  Xianghua Ye; Jinsong Yang; Justin Stebbing; Ling Peng
Journal:  BMC Pulm Med       Date:  2022-02-05       Impact factor: 3.317

6.  Early postoperative radiotherapy is associated with improved outcomes over late postoperative radiotherapy in the management of completely resected (R0) Stage IIIA-N2 non-small cell lung cancer.

Authors:  Huan-Huan Wang; Lei Deng; Qing-Lian Wen; Chun-Ze Zhang; Nicholas G Zaorsky; Bai-Lin Zhang; Jie Chen; Xian-Liang Zeng; Yao-Li Cui; Yang-Yang Shi; Hai-Ling Hou; Wei Wang; Bo Jiang; Jun Wang; Qing-Song Pang; Lu-Jun Zhao; Zhi-Yong Yuan; Ping Wang; Mao-Bin Meng
Journal:  Oncotarget       Date:  2017-05-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.